Generalizing/Transporting the results

  • Inoue K, Hsu W, Arah OA, Prosper A, Aberle D, Bui A. (2021). Generalizability and transportability of the results from randomized controlled trials: An example using the National Lung Screening Trial. Cancer Epidemiology, Biomarkers & Prevention: 30(12), 2227-2234.
  • Inoue K, Athey S, Tsugawa Y. (2023). Machine-learning-based high-benefit approach versus conventional high-risk approach in blood pressure management. International Journal of Epidemiology.52(4):1243-1256.
  • Prosper A, Inoue K (co-first), Kathleen B, Bui A, Aberle D, Hsu W. (2021). Association of Inclusion of More Black Individuals in Lung Cancer Screening With Reduced Mortality. JAMA Network Open: 4(8), e2119629-e2119629
  • Inoue K, Watson KE, Kondo N, Horwich T, Hsu W, Bui A, Duru OK. (2022). Association of Intensive Blood Pressure Control and Living Arrangement on Cardiovascular Outcomes by Race. JAMA Network Open; 1;5(3):e222037